AIM Vaccine Co (HKSE:06660) Interest Income : HK$8 Mil (TTM As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is AIM Vaccine Co Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. AIM Vaccine Co's interest income for the six months ended in Dec. 2024 was HK$3 Mil. Its interest income for the trailing twelve months (TTM) ended in Dec. 2024 was HK$8 Mil.

AIM Vaccine Co Interest Income Historical Data

The historical data trend for AIM Vaccine Co's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AIM Vaccine Co Interest Income Chart

AIM Vaccine Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Income

Get a 7-Day Free Trial

12.73

13.20

11.94

11.71

8.00

AIM Vaccine Co Semi-Annual Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Interest Income	Get a 7-Day Free Trial				7.59	5.94	5.77	4.69	3.35

AIM Vaccine Co Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$8 Mil.

AIM Vaccine Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AIM Vaccine Co Ltd (HKSE:06660) » Definitions » Interest Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

91 Jianguo Road, 25th Floor, Building A, Chaoyang, Beijing, CHN

Website

https://www.aimbio.com

AIM Vaccine Co Ltd is a top full-chain vaccine corporation in China with businesses covering the whole industrial chain ranging from research and development to manufacturing and commercialization. The Vaccine products include Recombinant HBV Vaccines, Freeze-dried Human Rabies Vaccine, Inactivated HAV Vaccines, Group A, C, Y, and W135 MPSV, Bivalent Inactivated HFRS Vaccine, and Mumps Vaccine. It generates all of its revenues in the PRC.

Executives

Shang Hai Xun Jing Qi Ye Guan Li Zhong Xin You Xian He Huo	2201 Interest of corporation controlled by you
Xi Zang Ying Feng Shi Ye You Xian Gong Si	2101 Beneficial owner
Yang Aihua	2201 Interest of corporation controlled by you
Zhao Yin Jin Rong Kong Gu Shen Zhen You Xian Gong Si	2201 Interest of corporation controlled by you
Zhao Shang Yin Xing Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong You Xian Gong Si	2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong Kong Gu You Xian Gong Si	2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Zi Ben Guan Li Shen Zhen You Xian Gong Si	2201 Interest of corporation controlled by you
Ning Bo Shi Bei Lun Qu Guo You Zi Ben Yun Ying You Xian Gong Si	2201 Interest of corporation controlled by you
Ning Bo Bao Shui Qu Kong Gu You Xian Gong Si	2101 Beneficial owner
Chang Wei	2201 Interest of corporation controlled by you
Wang Aijun	2201 Interest of corporation controlled by you
China Merchants Bank Co., Ltd.	2201 Interest of corporation controlled by you
Zhang Kuo	2201 Interest of corporation controlled by you
Zhang Chong	2201 Interest of corporation controlled by you

AIM Vaccine Co Headlines

No Headlines